214 related articles for article (PubMed ID: 30705091)
1. Dopamine transporter forms stable dimers in the live cell plasma membrane in a phosphatidylinositol 4,5-bisphosphate-independent manner.
Das AK; Kudlacek O; Baumgart F; Jaentsch K; Stockner T; Sitte HH; Schütz GJ
J Biol Chem; 2019 Apr; 294(14):5632-5642. PubMed ID: 30705091
[TBL] [Abstract][Full Text] [Related]
2. PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein.
Hamilton PJ; Belovich AN; Khelashvili G; Saunders C; Erreger K; Javitch JA; Sitte HH; Weinstein H; Matthies HJG; Galli A
Nat Chem Biol; 2014 Jul; 10(7):582-589. PubMed ID: 24880859
[TBL] [Abstract][Full Text] [Related]
3. Effect of palmitoylation on the dimer formation of the human dopamine transporter.
Zeppelin T; Pedersen KB; Berglund NA; Periole X; Schiøtt B
Sci Rep; 2021 Feb; 11(1):4164. PubMed ID: 33602981
[TBL] [Abstract][Full Text] [Related]
4. Single molecule analysis reveals coexistence of stable serotonin transporter monomers and oligomers in the live cell plasma membrane.
Anderluh A; Klotzsch E; Reismann AW; Brameshuber M; Kudlacek O; Newman AH; Sitte HH; Schütz GJ
J Biol Chem; 2014 Feb; 289(7):4387-94. PubMed ID: 24394416
[TBL] [Abstract][Full Text] [Related]
5. Dopamine transporter oligomerization involves the scaffold domain, but spares the bundle domain.
Jayaraman K; Morley AN; Szöllősi D; Wassenaar TA; Sitte HH; Stockner T
PLoS Comput Biol; 2018 Jun; 14(6):e1006229. PubMed ID: 29874235
[TBL] [Abstract][Full Text] [Related]
6. Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier.
Kahlig KM; Javitch JA; Galli A
J Biol Chem; 2004 Mar; 279(10):8966-75. PubMed ID: 14699142
[TBL] [Abstract][Full Text] [Related]
7. A juxtamembrane mutation in the N terminus of the dopamine transporter induces preference for an inward-facing conformation.
Guptaroy B; Zhang M; Bowton E; Binda F; Shi L; Weinstein H; Galli A; Javitch JA; Neubig RR; Gnegy ME
Mol Pharmacol; 2009 Mar; 75(3):514-24. PubMed ID: 19098122
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous inward opening of the dopamine transporter is triggered by PIP2-regulated dynamics of the N-terminus.
Khelashvili G; Stanley N; Sahai MA; Medina J; LeVine MV; Shi L; De Fabritiis G; Weinstein H
ACS Chem Neurosci; 2015 Nov; 6(11):1825-37. PubMed ID: 26255829
[TBL] [Abstract][Full Text] [Related]
9. Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport.
Midde NM; Yuan Y; Quizon PM; Sun WL; Huang X; Zhan CG; Zhu J
J Neuroimmune Pharmacol; 2015 Mar; 10(1):122-35. PubMed ID: 25604666
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters.
Eshleman AJ; Nagarajan S; Wolfrum KM; Reed JF; Swanson TL; Nilsen A; Janowsky A
Psychopharmacology (Berl); 2019 Mar; 236(3):939-952. PubMed ID: 30397775
[TBL] [Abstract][Full Text] [Related]
11. Raman Spectroscopic Signature Markers of Dopamine-Human Dopamine Transporter Interaction in Living Cells.
Silwal AP; Yadav R; Sprague JE; Lu HP
ACS Chem Neurosci; 2017 Jul; 8(7):1510-1518. PubMed ID: 28375605
[TBL] [Abstract][Full Text] [Related]
12. Functional properties of dopamine transporter oligomers after copper linking.
Zhen J; Reith MEA
J Neurochem; 2018 Jan; 144(2):162-171. PubMed ID: 29168892
[TBL] [Abstract][Full Text] [Related]
13. PI 3-kinase regulation of dopamine uptake.
Carvelli L; Morón JA; Kahlig KM; Ferrer JV; Sen N; Lechleiter JD; Leeb-Lundberg LM; Merrill G; Lafer EM; Ballou LM; Shippenberg TS; Javitch JA; Lin RZ; Galli A
J Neurochem; 2002 May; 81(4):859-69. PubMed ID: 12065645
[TBL] [Abstract][Full Text] [Related]
14. Direct PIP
Anderluh A; Hofmaier T; Klotzsch E; Kudlacek O; Stockner T; Sitte HH; Schütz GJ
Nat Commun; 2017 Jan; 8():14089. PubMed ID: 28102201
[TBL] [Abstract][Full Text] [Related]
15. Sequence determinants of the Caenhorhabditis elegans dopamine transporter dictating in vivo axonal export and synaptic localization.
Robinson SB; Hardaway JA; Hardie SL; Wright J; Glynn RM; Bermingham DP; Han Q; Sturgeon SM; Freeman P; Blakely RD
Mol Cell Neurosci; 2017 Jan; 78():41-51. PubMed ID: 27913309
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of psychoactive substances on human wildtype and polymorphic T356M dopamine transporters (DAT).
Zwartsen A; Litjens CHC; Hondebrink L; van den Heuvel JJMW; Greupink R; Russel FGM; de Lange DW; Legler J; Koenderink JB; Westerink RHS
Toxicology; 2019 Jun; 422():69-75. PubMed ID: 31009648
[TBL] [Abstract][Full Text] [Related]
17. Mutation of tyrosine 470 of human dopamine transporter is critical for HIV-1 Tat-induced inhibition of dopamine transport and transporter conformational transitions.
Midde NM; Huang X; Gomez AM; Booze RM; Zhan CG; Zhu J
J Neuroimmune Pharmacol; 2013 Sep; 8(4):975-87. PubMed ID: 23645138
[TBL] [Abstract][Full Text] [Related]
18. Allosteric modulation of human dopamine transporter activity under conditions promoting its dimerization.
Cheng MH; Garcia-Olivares J; Wasserman S; DiPietro J; Bahar I
J Biol Chem; 2017 Jul; 292(30):12471-12482. PubMed ID: 28584050
[TBL] [Abstract][Full Text] [Related]
19. Amphetamine activates calcium channels through dopamine transporter-mediated depolarization.
Cameron KN; Solis E; Ruchala I; De Felice LJ; Eltit JM
Cell Calcium; 2015 Nov; 58(5):457-66. PubMed ID: 26162812
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport.
Quizon PM; Sun WL; Yuan Y; Midde NM; Zhan CG; Zhu J
Sci Rep; 2016 Dec; 6():39048. PubMed ID: 27966610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
